Extracted from this filing and checked against the source text.
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
Aditxt, Inc.: Filed Certificate of Designation for Series A-1 Convertible Preferred Stock with the Delaware Secretary of State (effective 2023-12-22).
- Change
- charter amendment
- Effective
- 2023-12-22
Exact text from the filing
On December 22, 2023, the Company filed a Certificate of Designation for its Series A-1 Preferred Stock with the Secretary of State of Delaware (the “ Series A-1 Certificate of Designations ”).
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Aditxt, Inc. entered into Registration Rights Agreement with Holders of Evofem Series F-1 Convertible Preferred Stock valued at Registration Rights Agreement covering resale of Conversion Shares (effective 2023-12-26).
- Action
- entry
- Counterparty
- Holders of Evofem Series F-1 Convertible Preferred Stock
- Value
- Registration Rights Agreement covering resale of Conversion Shares
- Effective
- 2023-12-26
Exact text from the filing
On December 26, 2023, in connection with the Exchange Agreement, the Company entered into a Registration Rights Agreement with the Holders (the “ Registration Rights Agreement ”), pursuant to which the Company agreed to prepare and file with the Securities and Exchange Commission (the “ SEC ”) a registration statement on Form S-3 (the “ Registration Statement ”) covering the resale of the shares of the Company’s common stock, par value $0.001 (the “ Common Stock ”) issuable upon conversion of the Series A-1 Preferred Stock (the “ Conversion Shares ”)
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Aditxt, Inc. entered into Exchange Agreement with holders of Evofem Series F-1 Convertible Preferred Stock valued at Exchange of 22,280 shares of Evofem Series F-1 Preferred Stock for 22,280 shares of Company Series A (effective 2023-12-22).
- Action
- entry
- Counterparty
- holders of Evofem Series F-1 Convertible Preferred Stock
- Value
- Exchange of 22,280 shares of Evofem Series F-1 Preferred Stock for 22,280 shares of Company Series A
- Effective
- 2023-12-22
Exact text from the filing
on December 22, 2023, the Company entered into an Exchange Agreement (the “ Exchange Agreement ”) with the holders (the “ Holders ”) of an aggregate of 22,280 shares of Series F-1 Convertible Preferred Stock of Evofem (the “ Evofem Series F-1 Preferred Stock ”) agreed to exchange their respective shares of Evofem Series F-1 Preferred Stock for an aggregate of 22,280 shares of a new series of convertible preferred stock of the Company designated as Series A-1 Convertible Preferred Stock, $0.001 par value, (the “ Series A-1 Preferred Stock ”)
View on SEC.gov